The prognostic value of N-terminal proB-type natriuretic peptide (Q36304293)

13 August 2017

1 reference

title

The prognostic value of N-terminal proB-type natriuretic peptide (English)

1 reference

13 August 2017

author name string

Lisa C Costello-Boerrigter

series ordinal

1

1 reference

13 August 2017

John C Burnett

series ordinal

2

1 reference

13 August 2017

publication date

1 April 2005

1 reference

Nature Clinical Practice Cardiovascular Medicine

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

4

1 reference

13 August 2017

page(s)

194-201

1 reference

Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Deconvolution analysis of cardiac natriuretic peptides during acute volume overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Low pro-brain natriuretic peptide levels predict benign clinical outcome in acute pulmonary embolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Changes in production and metabolism of brain natriuretic peptide in rats with myocardial necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

Role of actin in regulation of epithelial sodium channels by CFTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

Use of NT-proBNP in routine testing and comparison to BNP.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

NT-proBNP in heart failure: therapy decisions and monitoring.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF).

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

Natriuretic peptides for risk stratification of patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0156

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0156

1 reference

Dimensions Publication ID

13 August 2017

1028133985

0 references

1 reference